🇸🇬 Hu38Sb19 in Singapore

Hu38Sb19 (isatuximab) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Hu38Sb19 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Hu38Sb19 approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Hu38Sb19 in Singapore?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.